Rchr
J-GLOBAL ID：202101015985252948
Update date: Nov. 03, 2024
Nakagawa Ryo
中川 良 | Nakagawa Ryo
Affiliation and department：
Research theme for competitive and other funds (3)：
- 2018 - 2021 Screening of Ras inhibitors for clinical application in primary cholangitis
- 2018 - 2020 Development of Ras Inhibitory Therapy for Autoimmune Liver Diseases
- 2016 - 2018 Development of Ras Inhibitory Therapy for Chronic Liver Diseases
Papers (71)：
-
Tomomi Ozaki, Sae Yumita, Sadahisa Ogasawara, Makoto Fujiya, Takahiro Tsuchiya, Ryohei Yoshino, Midori Sawada, Teppei Akatsuka, Ryo Izai, Chihiro Miwa, et al. Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
-
Goto Chihiro, Nakagawa Ryo, Horio Ryousuke, Kurosugi Akane, Sonoda Michiko, Kaneko Tatsuya, Kojima Ryuta, Akizue Naoki, Ohta Yuki, Taida Takashi, et al. The association between gene expression patterns in gastric mucosa after Helicobacter pylori eradication and the recurrence of gastric cancer. Japan Journal of Molecular Tumor Marker Research. 2024. 39. 26-27
-
Ariki Nagashima, Kenichiro Okimoto, Ryo Nakagawa, Naoki Akizue, Tomoaki Matsumura, Hirotaka Oura, Ryuta Kojima, Chihiro Goto, Satsuki Takahashi, Ryosuke Horio, et al. Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profiling. Scientific reports. 2023. 13. 1. 19661-19661
-
後藤 千尋, 中川 良, 堀尾 亮輔, 黒杉 茜, 園田 美智子, 金子 達哉, 兒島 隆太, 明杖 直樹, 太田 佑樹, 對田 尚, et al. Helicobacter pylori除菌後胃粘膜の遺伝子発現パターンと胃癌再発の関連の検討. 日本分子腫瘍マーカー研究会プログラム・講演抄録. 2023. 43回. 70-71
-
Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, Norio Itokawa, Ryohei Yoshino, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, et al. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs - real world outcomes. 2023
ｍore...
MISC (47)：
-
澤田翠, 小林和史, 叶川直哉, 宇野澤秀美, 藤本健太郎, 弓田冴, 石野貴雅, 小川慶太, 藤原希彩子, 興梠慧輔, et al. Atezolizumab+Bevacizumab併用療法導入後5カ月後に急速に縮小を認めた肝細胞癌の1例. 日本消化器病学会関東支部例会プログラム・抄録集. 2023. 377th
-
山田奈々, 大山広, 中川良, 菅元泰, 關根優, 遠山翔大, 杉原地平, 大内麻愉, 永嶌裕樹, 飯野陽太郎, et al. 当院における自己免疫性膵炎についての臨床学的検討. 日本消化器病学会雑誌(Web). 2023. 120
-
大野 泉, 山田 俊儒, 對田 尚, 中川 良, 杉原 地平, 大内 麻愉, 菅 元泰, 丸田 四季子, 三浦 義史, 永嶌 裕樹, et al. 膵癌診療における真菌叢解析の可能性. 日本消化器病学会雑誌. 2022. 119. 臨増大会. A784-A784
-
神崎 洋彰, 小笠原 定久, 吉田 亮伊, 吉埜 稜平, 弓田 冴, 石野 貴雅, 小川 慶太, 中川 美由貴, 藤原 希彩子, 宇野澤 秀美, et al. 進行肝細胞癌に対するシーケンシャル療法におけるカボザンチニブ治療の実際. 肝胆膵. 2022. 85. 1. 144-145
-
Ariki Nagashima, Kenichiro Okimoto, Ryo Nakagawa, Naoki Akizue, Tomoaki Matsumura, Hirotaka Oura, Ryuta Kojima, Chihiro Goto, Satsuki Takahashi, Ryosuke Horio, et al. CHRONIC INFLAMMATION WITH INTERFERON ALPHA RESPONSE IS A RISK FOR CARCINOGENESIS OF GASTRIC CANCER AFTER HELICOBACTER PYLORI ERADICATION. GASTROENTEROLOGY. 2022. 162. 7. S1055-S1055
ｍore...
Return to Previous Page
